Dr. Kammula is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
5150 Centre Avenue
Pittsburgh, PA 15232Phone+1 412-692-2852Fax+1 412-647-4486- Is this information wrong?
Education & Training
- Memorial Sloan Kettering Cancer CenterFellowship, Complex General Surgical Oncology, 2002 - 2004
- University of ChicagoResidency, Surgery, 1994 - 2002
- University of Maryland School of MedicineClass of 1994
Certifications & Licensure
- PA State Medical License 2017 - 2024
- NY State Medical License 2002 - 2017
- MD State Medical License Active through 2014
- IL State Medical License 1996 - 2002
- American Board of Surgery Surgery
Awards, Honors, & Recognition
- Fellow American College of Surgeons
Clinical Trials
- Chemotherapy Followed by gp100 Lymphocytes and Aldesleukin to Treat Melanoma Start of enrollment: 2008 Apr 01
- Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Ocular Melanoma Start of enrollment: 2013 Mar 01
- Adoptive Transfer of Tumor Infiltrating Lymphocytes for Metastatic Uveal Melanoma Start of enrollment: 2018 May 14
- Join now to see all
Publications & Presentations
PubMed
- 2 citationsGenome-wide gain-of-function screening characterized lncRNA regulators for tumor immune response.Yifei Wang, Yueshan Zhao, Weiwei Guo, Ghanshyam Singh Yadav, Chetana Bhaskarla, Zehua Wang, Xiaofei Wang, Sihan Li, Yue Wang, Yuang Chen, Dhamotharan Pattarayan, Wen X...> ;Science Advances. 2022 Dec 9
- 6 citationsIn Vivo Priming of Peritoneal Tumor-Reactive Lymphocytes With a Potent Oncolytic Virus for Adoptive Cell TherapyEsther Giehl, Hiromichi Kosaka, Zuqiang Liu, Mathilde Feist, Udai S. Kammula, Michael T. Lotze, Congrong Ma, Zong Sheng Guo, David L. Bartlett> ;Frontiers in Immunology. 2021 Feb 18
- 26 citationsLincRNA-immunity landscape analysis identifies EPIC1 as a regulator of tumor immune evasion and immunotherapy resistance.Weiwei Guo, Yue Wang, Min Yang, Zehua Wang, Yifei Wang, Smriti Chaurasia, Zhiyuan Wu, Min Zhang, Ghanshyam Singh Yadav, Sanjay Rathod, Fernando Concha-Benavente, Chris...> ;Science Advances. 2021 Feb 10
- Join now to see all
Press Mentions
- Beckwith Institute Awards Research GrantsJune 30th, 2021
- Why Everyone Should Care About Uveal MelanomaDecember 7th, 2018
- New Insights Could Unlock Immunotherapy for Rare, Deadly Eye CancerApril 17th, 2024
Professional Memberships
- Member
Hospital Affiliations
- UPMC Presbyterian ShadysidePittsburgh, Pennsylvania
- UPMC Magee-Womens HospitalPittsburgh, Pennsylvania
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: